Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trial

Claudia M. Denkinger, Michaël Schmitt, U. Schäkel et al.|medRxiv|2022

Cited by 4